Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
11/2011
11/02/2011CN102232076A Pyrrolopyrazinyl urea kinase inhibitors
11/02/2011CN102232075A Amino pyrazole compound
11/02/2011CN102229612A Method for extracting chlorophyll Cu from silkworm excrements
11/02/2011CN102229611A 2,6-diaryl pyrazolo[1,5-a]pyrazine-4(5H)-ketone compound and its application
11/02/2011CN102229610A Method for synthesizing optical pure chiral 1,2,3,4-tetrahydropyrrole[1,2-a] pyrazine compound
11/02/2011CN102229609A Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
11/02/2011CN101547692B Antidepressant, neuroprotectant, amyloid beta deposition inhibitor or age retardant containing heterocyclic compound having specific structure
11/02/2011CN101516887B Thiazole pyrazolopyrimidines as crf1 receptor antagonists
11/01/2011US8049411 Material for organic electroluminescence device and organic electroluminescence device using the same
11/01/2011US8049008 Reverse-turn mimetics and method relating thereto
11/01/2011US8048906 Optically pure and enriched isomers of chelating ligands and contrast agents
11/01/2011US8048895 Kappa opioid receptor ligands
11/01/2011US8048893 Pyrazolyl derivatives, preparation process and intermediates of this process as medicinal products and pharmaceutical compositions containing them
11/01/2011US8048872 Treatment of hyperproliferative diseases with vinca alkaloid N-oxide and analogs
11/01/2011US8048642 Heme choline esters and uses thereof
11/01/2011CA2653034C Macrocyclic oximyl hepatitis c protease inhibitors
11/01/2011CA2649521C Novel piperazine compound, and use thereof as hcv polymerase inhibitor
11/01/2011CA2521854C Inhibitors of cyclin-dependent kinases, compositions and uses related thereto
11/01/2011CA2476586C Sulfonyl-derivatives as novel inhibitors of histone deacetylase
11/01/2011CA2409741C Tnf-.alpha. production inhibitors
10/2011
10/27/2011WO2011133750A1 Indazole compounds useful as ketohexokinase inhibitors
10/27/2011WO2011133722A2 Anti-viral compounds
10/27/2011WO2011133637A2 Compounds and methods for kinase modulation, and indications therefor
10/27/2011WO2011133182A1 Modulators of 5-ht receptors and methods of use thereof
10/27/2011WO2011132866A1 Novel compounds for organic electronic material and organic electroluminescent device using the same
10/27/2011WO2011132865A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
10/27/2011WO2011132712A1 Novel hydroxamic acid derivative
10/27/2011WO2011132048A1 Heteroaryl compounds as pde10a inhibitors
10/27/2011WO2011131596A1 Heteroaryl-cyclohexyl-tetraazabenzo[e]azulenes as vasopressin v1a receptor antagonists
10/27/2011WO2011131571A1 Pyrrazolopyridine derivatives
10/27/2011WO2011130859A1 Controlled release formulation based on hematin anhydride crystals for the induction of an innate immune reaction
10/27/2011WO2011047319A8 Antimicrobial compounds and methods of making and using the same
10/27/2011WO2011040800A3 Synthesis of boron dipyrromethenes with laser properties
10/27/2011US20110264027 B ring reduced-d ring oxidized tetrapyrollic photosensitizers for photodynamic therapy and tumor imaging
10/27/2011US20110263851 Processes for preparing intermediates of pemetrexed
10/27/2011US20110263850 Process for the preparation of anagrelide and analogues
10/27/2011US20110263848 Process of a quaternary ammonium salt using phosphate
10/27/2011US20110263847 Process of a quaternary ammonium salt
10/27/2011US20110263844 method for preparing macrocycles
10/27/2011US20110263669 Novel Pyrrolo [2,3-A] Carbazoles and Use Thereof as PIM Kinase Inhibitors
10/27/2011US20110263610 Compounds and compositions as itpkb inhibitors
10/27/2011US20110263608 16-keto aspergillimides and harmful organism control agent comprising the same as active ingredient
10/27/2011US20110263607 Alpha helix mimetics in the treatment of cancer
10/27/2011US20110263605 Azabicyclo[2.2.1]Heptane Compounds as Alpha-7 Nicotinic Acetylcholine Receptor Ligands
10/27/2011US20110263598 Kinase inhibitors and method of treating cancer
10/27/2011US20110263597 Substituted pyridines and pyridazines with angiogenesis inhibiting activity
10/27/2011US20110263595 Compounds and methods for kinase modulation, and indications therefor
10/27/2011US20110263578 Heteroaryl-cyclohexyl-tetraazabenzo[e]azulenes
10/27/2011US20110263575 Compounds Useful as Protein Kinase Inhibitors
10/27/2011US20110263573 Heterobiaryl-cyclohexyl-tetraazabenzo[e]azulenes
10/27/2011US20110263559 Indazole compounds useful as ketohexokinase inhibitors
10/27/2011US20110263532 Halofuginone analogs for inhibition of trna synthetases and uses thereof
10/27/2011US20110262970 Enzymatic Hydrolysis Of Pretreated Lignocellulose-Containing Material With Cationic Polysaccharides
10/27/2011US20110262397 Compounds, compositions, and methods for control of hepatitis c viral infections
10/27/2011US20110262357 Metalloporphyrin Derivatives, Nanoparticles Comprising the Same, and Use Thereof for Photodynamic Therapy
10/27/2011CA2812043A1 Pyrimidinedione anti-viral compounds
10/27/2011CA2797019A1 Modulators of 5-ht receptors and methods of use thereof
10/27/2011CA2796637A1 Certain amino-pyrimidines, compositions thereof, and methods for their use
10/27/2011CA2795526A1 Heteroaryl-cyclohexyl-tetraazabenzo[e]azulenes as vasopressin v1a receptor antagonists
10/27/2011CA2786837A1 Pyrrazolopyridine derivatives
10/26/2011EP2380882A1 Salts of heterocyclic anions and their uses as ionic conductive materials
10/26/2011EP2379561A2 Mlk inhibitors and methods of use
10/26/2011EP2379560A1 Process for making a crystalline zilpaterol salt
10/26/2011EP2379559A2 Pyrimido-diazepinone kinase scaffold compounds and methods of treating disorders
10/26/2011EP2379558A1 Novel heterocyclic compounds for use as metap-2 inhibitors
10/26/2011EP2379557A1 Amino pyrazole compound
10/26/2011EP2379556A1 Substituted 1h-pyrazolo[3,4-d]pyrimidine-6-amine compounds
10/26/2011EP2379553A1 Bicyclic compounds for the reduction of beta-amyloid production
10/26/2011EP2379551A1 Substituted pyrazolo [3, 4-b]pyridine compounds
10/26/2011EP2379523A1 4, 6-disubstituted 2-amino-pyrimidines as histamine h4 receptor modulators
10/26/2011EP2379513A1 Heteroaryl compounds useful as raf kinase inhibitors
10/26/2011EP2170890B1 Cytotoxic agents comprising new tomaymycin derivatives and their therapeutic use
10/26/2011EP2057141B1 Pyrimidone compounds as gsk-3 inhibitors
10/26/2011EP1984454B1 Method of manufacturing a phthalocyanine compound
10/26/2011EP1756112B1 Pyrrolobenzimidazolones and their use as antiproliferative agents
10/26/2011EP1518855B1 Diaminopyrimidinecarboxa mide derivative
10/26/2011CN1980934B Novel indole derivatives as selective androgen receptor modulators (sarms)
10/26/2011CN102227432A Process for preparing chlorins and their pharmaceutical uses
10/26/2011CN102227431A Indole and indoline derivatives and methods of use thereof
10/26/2011CN102227430A Modulators of cystic fibrosis transmembrane conductance regulator
10/26/2011CN102227429A 3-aminocyclopentanecarboxamides as chemokine receptor modulators
10/26/2011CN102227428A Arylcyclohexylethers of dihydrotetraazabenzoazulenes for use as vasopressin via receptor antagonists
10/26/2011CN102227422A Heterocyclic jak kinase inhibitors
10/26/2011CN102227421A Anti-proliferation compounds
10/26/2011CN102227407A Hepatitis c virus inhibitors
10/26/2011CN102225926A Pharmaceutically acceptable salts of quinolinone compounds having improved pharmaceutical properties
10/26/2011CN101415705B Compounds and methods for inhibiting hepatitis c viral replication
10/25/2011US8044103 Cyclic dipeptides and azetidinone compounds and their use in treating CNS injury and neurodegenerative disorders
10/25/2011US8044064 Fused pyrrolocarbazoles
10/25/2011US8044060 6-cyclylmethyl- and 6-alkylmethyl pyrazolo[3,4-D]pyrimidines, methods for their preparation and methods for their use to treat impairments of perception, concentration learning and/or memory
10/25/2011US8044050 Imidazo[1,2-a]azines and their use as pharmaceuticals
10/25/2011US8044049 Fused heterocyclic derivative and use thereof
10/25/2011CA2581225C Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
10/25/2011CA2518299C 8-substituted-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one derivatives
10/25/2011CA2516937C Substituted 8'-pyridinyl-dihydrospiro-[cycloalkyl]-pyrimido[1,2-a]pyrimidin-6-one and 8'-pyrimidinyl-dihydrospiro-[cycloalkyl]-pyrimido[1,2-a]pyrimidin-6-one derivatives and theiruse against neurogenerative diseases
10/20/2011WO2011130692A2 Androgen induced oxidative stress inhibitors
10/20/2011WO2011130598A1 Pyrrolobenzodiazepines and conjugates thereof
10/20/2011WO2011130481A1 Pyrrolopyrazinone inhibitors of kinases
10/20/2011WO2011130146A1 5, 7-substituted-imidazo [1, 2-c] pyrimidines as inhibitors of jak kinases
10/20/2011WO2011128650A1 Intermediates useful for the synthesis of pyrrolobenzodiazepines
1 ... 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 ... 573